Neural and Psychiatric Consequences of Cannabis Use in Adolescents
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT06941298
- Status
- Recruiting
Conditions
- Cannabis Use
- Depression
Eligibility Criteria
- Sex
- ALL
- Age
- 14 Years - 20 Years
- Healthy Volunteers
- Accepted
Interventions
- Neuroimaging Investigation — BEHAVIORALParticipants will undergo fMRI neuroimaging at two timepoints, at the start of the study and at the 1 year follow up. The fMRI is one hour in duration. During the fMRI, participants will complete two tasks investigating diverse aspects of reward circuitry activity. After this is completed, participants will be followed up for another year clinically.
Study Details
The goal of this study is to investigate the effects of cannabis on brain function among adolescents with depression.
Key Dates
- Start date
- Mar 4, 2025
- Status verified
- Apr 2026
- Primary completion
- Jun 1, 2029
- Completion
- Jun 1, 2029
Study Design
- Enrollment
- 280 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Neuroimaging Investigation GroupParticipants in this group will receive neuroimaging investigation for up to 2 years.
Primary Outcome Measure
Depression Severity measured by the Beck Depression Inventory (BDI) [ Time Frame: Up to 3 years ]
Central Contacts
- Vilma Gabbay, MD, JD, MS305-243-5510
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami Clinical Research Building | Miami | Florida | 33136 | Vilma Gabbay, MD, JD, MS (PRINCIPAL_INVESTIGATOR) Benjamin Ely, PhD (SUB_INVESTIGATOR) |
| Nathan Kline Institute | Orangeburg | New York | 10962 | Russell Tobe, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
By condition
By specialty
Related Studies
- Lay-Delivered Behavioral Activation in Senior CentersRecruiting · University of Washington · Brandon, Florida
- Safe Mothers, Safe Children InitiativeRecruiting · New York University · New York, New York
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
- Accelerated TMS for Depression and OCDRecruiting · Weill Medical College of Cornell University · New York, New York